Gary M. Winer - 14 Jun 2024 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
Director
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact for Gary M. Winer
Issuer symbol
HCWB
Transactions as of
14 Jun 2024
Net transactions value
$0
Form type
4
Filing time
17 Jun 2024, 16:56:16 UTC
Previous filing
09 May 2024
Next filing
14 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCWB Stock Option (Right to Buy) Award $0 +12,500 $0.000000 12,500 14 Jun 2024 Common Stock 12,500 $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 13, 2025 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date.